APO RESEARCH · REPORT
Sodium Hyaluronate Eye Drops
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Product & engineering
Understand the product.
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Selected research
Industry Research
Sodium Hyaluronate Eye Drops Industry Research Report 2026
Market perspective
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Global Sodium Hyaluronate Eye Drops key players include URSAPHARM, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, etc. Global top five manufacturers hold a share about 40%.
Asia-Pacific is the largest market, with a share over 45%, followed by North America and Europe, both have a share over 35 percent.
Read the full market overview
In terms of product, 0.10% is the largest segment, with a share about 40%. And in terms of application, the largest application is Dry Eye, followed by Rewetting.
Report Scope
This report quantifies the global Sodium Hyaluronate Eye Drops market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sodium Hyaluronate Eye Drops Market by Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Sodium Hyaluronate Eye Drops Segment by Type
0.001
0.0015
0.003
Others
Sodium Hyaluronate Eye Drops Segment by Application
Dry Eye
Rewetting
Others
Sodium Hyaluronate Eye Drops Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Hyaluronate Eye Drops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Hyaluronate Eye Drops and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Hyaluronate Eye Drops.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sodium Hyaluronate Eye Drops manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sodium Hyaluronate Eye Drops by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sodium Hyaluronate Eye Drops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.001
- 0.0015
- 0.003
- Others
Applications
- Dry Eye
- Rewetting
- Others
Companies covered
- URSAPHARM Arzneimittel GmbH
- Santen
- Bayer Inc.
- Bausch & Lomb
- Johnson & Johnson
- The United Laboratories
- Alcon
- Novax Pharma
- Rohto
- Thea Pharmaceuticals
- Scope Ophthalmics Ltd
- Prestige Consumer Healthcare
- Medicom Healthcare Ltd
- Altacor
- Optrex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sodium Hyaluronate Eye Drops Market Size (2021-2032)
- 2.2.2 Global Sodium Hyaluronate Eye Drops Sales (2021-2032)
- 2.2.3 Global Sodium Hyaluronate Eye Drops Market Average Price (2021-2032)
- 2.3 Sodium Hyaluronate Eye Drops by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.001
- 2.3.3 0.0015
- 2.3.4 0.003
- 2.3.5 Others
- 2.4 Sodium Hyaluronate Eye Drops by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dry Eye
- 2.4.3 Rewetting
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sodium Hyaluronate Eye Drops Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sodium Hyaluronate Eye Drops Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Sodium Hyaluronate Eye Drops Revenue of Manufacturers (2021-2026)
- 3.4 Global Sodium Hyaluronate Eye Drops Average Price by Manufacturers (2021-2026)
- 3.5 Global Sodium Hyaluronate Eye Drops Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sodium Hyaluronate Eye Drops, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sodium Hyaluronate Eye Drops, Product Type & Application
- 3.8 Global Manufacturers of Sodium Hyaluronate Eye Drops, Established Date
- 3.9 Global Sodium Hyaluronate Eye Drops Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 URSAPHARM Arzneimittel GmbH
- 4.1.1 URSAPHARM Arzneimittel GmbH Company Information
- 4.1.2 URSAPHARM Arzneimittel GmbH Business Overview
- 4.1.3 URSAPHARM Arzneimittel GmbH Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 URSAPHARM Arzneimittel GmbH Sodium Hyaluronate Eye Drops Product Portfolio
- 4.1.5 URSAPHARM Arzneimittel GmbH Recent Developments
- 4.2 Santen
- 4.2.1 Santen Company Information
- 4.2.2 Santen Business Overview
- 4.2.3 Santen Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Santen Sodium Hyaluronate Eye Drops Product Portfolio
- 4.2.5 Santen Recent Developments
- 4.3 Bayer Inc.
- 4.3.1 Bayer Inc. Company Information
- 4.3.2 Bayer Inc. Business Overview
- 4.3.3 Bayer Inc. Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bayer Inc. Sodium Hyaluronate Eye Drops Product Portfolio
- 4.3.5 Bayer Inc. Recent Developments
- 4.4 Bausch & Lomb
- 4.4.1 Bausch & Lomb Company Information
- 4.4.2 Bausch & Lomb Business Overview
- 4.4.3 Bausch & Lomb Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bausch & Lomb Sodium Hyaluronate Eye Drops Product Portfolio
- 4.4.5 Bausch & Lomb Recent Developments
- 4.5 Johnson & Johnson
- 4.5.1 Johnson & Johnson Company Information
- 4.5.2 Johnson & Johnson Business Overview
- 4.5.3 Johnson & Johnson Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Johnson & Johnson Sodium Hyaluronate Eye Drops Product Portfolio
- 4.5.5 Johnson & Johnson Recent Developments
- 4.6 The United Laboratories
- 4.6.1 The United Laboratories Company Information
- 4.6.2 The United Laboratories Business Overview
- 4.6.3 The United Laboratories Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 The United Laboratories Sodium Hyaluronate Eye Drops Product Portfolio
- 4.6.5 The United Laboratories Recent Developments
- 4.7 Alcon
- 4.7.1 Alcon Company Information
- 4.7.2 Alcon Business Overview
- 4.7.3 Alcon Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Alcon Sodium Hyaluronate Eye Drops Product Portfolio
- 4.7.5 Alcon Recent Developments
- 4.8 Novax Pharma
- 4.8.1 Novax Pharma Company Information
- 4.8.2 Novax Pharma Business Overview
- 4.8.3 Novax Pharma Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novax Pharma Sodium Hyaluronate Eye Drops Product Portfolio
- 4.8.5 Novax Pharma Recent Developments
- 4.9 Rohto
- 4.9.1 Rohto Company Information
- 4.9.2 Rohto Business Overview
- 4.9.3 Rohto Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Rohto Sodium Hyaluronate Eye Drops Product Portfolio
- 4.9.5 Rohto Recent Developments
- 4.10 Thea Pharmaceuticals
- 4.10.1 Thea Pharmaceuticals Company Information
- 4.10.2 Thea Pharmaceuticals Business Overview
- 4.10.3 Thea Pharmaceuticals Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Thea Pharmaceuticals Sodium Hyaluronate Eye Drops Product Portfolio
- 4.10.5 Thea Pharmaceuticals Recent Developments
- 4.11 Scope Ophthalmics Ltd
- 4.11.1 Scope Ophthalmics Ltd Company Information
- 4.11.2 Scope Ophthalmics Ltd Business Overview
- 4.11.3 Scope Ophthalmics Ltd Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Scope Ophthalmics Ltd Sodium Hyaluronate Eye Drops Product Portfolio
- 4.11.5 Scope Ophthalmics Ltd Recent Developments
- 4.12 Prestige Consumer Healthcare
- 4.12.1 Prestige Consumer Healthcare Company Information
- 4.12.2 Prestige Consumer Healthcare Business Overview
- 4.12.3 Prestige Consumer Healthcare Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Prestige Consumer Healthcare Sodium Hyaluronate Eye Drops Product Portfolio
- 4.12.5 Prestige Consumer Healthcare Recent Developments
- 4.13 Medicom Healthcare Ltd
- 4.13.1 Medicom Healthcare Ltd Company Information
- 4.13.2 Medicom Healthcare Ltd Business Overview
- 4.13.3 Medicom Healthcare Ltd Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Medicom Healthcare Ltd Sodium Hyaluronate Eye Drops Product Portfolio
- 4.13.5 Medicom Healthcare Ltd Recent Developments
- 4.14 Altacor
- 4.14.1 Altacor Company Information
- 4.14.2 Altacor Business Overview
- 4.14.3 Altacor Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Altacor Sodium Hyaluronate Eye Drops Product Portfolio
- 4.14.5 Altacor Recent Developments
- 4.15 Optrex
- 4.15.1 Optrex Company Information
- 4.15.2 Optrex Business Overview
- 4.15.3 Optrex Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Optrex Sodium Hyaluronate Eye Drops Product Portfolio
- 4.15.5 Optrex Recent Developments
5 Global Sodium Hyaluronate Eye Drops Market Scenario by Region
- 5.1 Global Sodium Hyaluronate Eye Drops Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sodium Hyaluronate Eye Drops Sales by Region: 2021-2032
- 5.2.1 Global Sodium Hyaluronate Eye Drops Sales by Region: 2021-2026
- 5.2.2 Global Sodium Hyaluronate Eye Drops Sales by Region: 2027-2032
- 5.3 Global Sodium Hyaluronate Eye Drops Revenue by Region: 2021-2032
- 5.3.1 Global Sodium Hyaluronate Eye Drops Revenue by Region: 2021-2026
- 5.3.2 Global Sodium Hyaluronate Eye Drops Revenue by Region: 2027-2032
- 5.4 North America Sodium Hyaluronate Eye Drops Market Facts & Figures by Country
- 5.4.1 North America Sodium Hyaluronate Eye Drops Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sodium Hyaluronate Eye Drops Sales by Country (2021-2032)
- 5.4.3 North America Sodium Hyaluronate Eye Drops Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sodium Hyaluronate Eye Drops Market Facts & Figures by Country
- 5.5.1 Europe Sodium Hyaluronate Eye Drops Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sodium Hyaluronate Eye Drops Sales by Country (2021-2032)
- 5.5.3 Europe Sodium Hyaluronate Eye Drops Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sodium Hyaluronate Eye Drops Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sodium Hyaluronate Eye Drops Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sodium Hyaluronate Eye Drops Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sodium Hyaluronate Eye Drops Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sodium Hyaluronate Eye Drops Market Facts & Figures by Country
- 5.7.1 South America Sodium Hyaluronate Eye Drops Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sodium Hyaluronate Eye Drops Sales by Country (2021-2032)
- 5.7.3 South America Sodium Hyaluronate Eye Drops Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sodium Hyaluronate Eye Drops Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sodium Hyaluronate Eye Drops Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sodium Hyaluronate Eye Drops Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sodium Hyaluronate Eye Drops Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sodium Hyaluronate Eye Drops Sales by Type (2021-2032)
- 6.1.1 Global Sodium Hyaluronate Eye Drops Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Sodium Hyaluronate Eye Drops Sales Market Share by Type (2021-2032)
- 6.2 Global Sodium Hyaluronate Eye Drops Revenue by Type (2021-2032)
- 6.2.1 Global Sodium Hyaluronate Eye Drops Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sodium Hyaluronate Eye Drops Revenue Market Share by Type (2021-2032)
- 6.3 Global Sodium Hyaluronate Eye Drops Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sodium Hyaluronate Eye Drops Sales by Application (2021-2032)
- 7.1.1 Global Sodium Hyaluronate Eye Drops Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Sodium Hyaluronate Eye Drops Sales Market Share by Application (2021-2032)
- 7.2 Global Sodium Hyaluronate Eye Drops Revenue by Application (2021-2032)
- 7.2.1 Global Sodium Hyaluronate Eye Drops Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sodium Hyaluronate Eye Drops Revenue Market Share by Application (2021-2032)
- 7.3 Global Sodium Hyaluronate Eye Drops Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sodium Hyaluronate Eye Drops Value Chain Analysis
- 8.1.1 Sodium Hyaluronate Eye Drops Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sodium Hyaluronate Eye Drops Production Mode & Process
- 8.2 Sodium Hyaluronate Eye Drops Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sodium Hyaluronate Eye Drops Distributors
- 8.2.3 Sodium Hyaluronate Eye Drops Customers
9 Global Sodium Hyaluronate Eye Drops Analyzing Market Dynamics
- 9.1 Sodium Hyaluronate Eye Drops Industry Trends
- 9.2 Sodium Hyaluronate Eye Drops Industry Drivers
- 9.3 Sodium Hyaluronate Eye Drops Industry Opportunities and Challenges
- 9.4 Sodium Hyaluronate Eye Drops Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst